Rx Import Report To Miss Deadline, May Be Released During Week Of Dec. 13
This article was originally published in The Pink Sheet Daily
Executive Summary
The report is due to Congress Dec. 8 under the Medicare Modernization Act. HHS Secretary Thompson says the report will not be delivered by that date but will be ready “very shortly.”
You may also be interested in...
HHS Import Report Gives No Ground: Savings Would Not Exceed 1%
Drug Importation Task Force Report suggests a limited, tightly regulated commercial import system is "feasible," but only if policymakers accept minimal savings and possible consequences on drug development. Report does not quantify costs of creating import system, but veto threat is explicit.
HHS Import Report Gives No Ground: Savings Would Not Exceed 1%
Drug Importation Task Force Report suggests a limited, tightly regulated commercial import system is "feasible," but only if policymakers accept minimal savings and possible consequences on drug development. Report does not quantify costs of creating import system, but veto threat is explicit.
Rx Import Report: Task Force May Miss Dec. 8 Deadline
CMS Administrator McClellan says the drug import task force, of which he is a member, will publish its report “as close to the deadline as possible.” The Dec. 8 deadline for delivering the report to Congress is mandated under the Medicare Modernization Act.